Two Sigma Investments’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.52M	Sell	234,307 -166,555	-42%	-$4.25M	﹤0.01%	1894
2025 Q4	$11.6M	Buy	400,862 +305,433	+320%	+$7.82M	0.02%	1021
2025 Q3	$1.8M	Buy	95,429 +23,748	+33%	+$375K	﹤0.01%	2202
2025 Q2	$1M	Sell	71,681 -79,888	-53%	-$1.12M	﹤0.01%	2248
2025 Q1	$2.37M	Buy	151,569 +66,725	+79%	+$940K	0.01%	1630
2024 Q4	$1.18M	Sell	84,844 -88,821	-51%	-$973K	﹤0.01%	2071
2024 Q3	$1.62M	Sell	173,665 -460,776	-73%	-$4.55M	﹤0.01%	1806
2024 Q2	$5.9M	Buy	634,441 +150,360	+31%	+$1.36M	0.01%	939
2024 Q1	$4.8M	Sell	484,081 -494,724	-51%	-$3.69M	0.01%	993
2023 Q4	$3.16M	Buy	+978,805	New	+$2.66M	0.01%	1231
2023 Q1	–	Sell	-145,336	Closed	-$2.15M	–	2951
2022 Q4	$2.15M	Buy	145,336 +82,528	+131%	+$1.44M	0.01%	1296
2022 Q3	$1.2M	Buy	+62,808	New	+$1.42M	﹤0.01%	1383
2022 Q2	–	Sell	-21,192	Closed	-$408K	–	2495
2022 Q1	$408K	Buy	+21,192	New	+$359K	﹤0.01%	2107
2021 Q3	–	Sell	-73,686	Closed	-$2.01M	–	4230
2021 Q2	$2.01M	Sell	73,686 -39,122	-35%	-$1.1M	0.01%	1860
2021 Q1	$3.26M	Buy	112,808 +63,978	+131%	+$2M	0.01%	1334
2020 Q4	$1.37M	Buy	+48,830	New	+$1.2M	﹤0.01%	1761